Related Experiment Video
Updated: Jun 15, 2026
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Prostate cancer-targeted imaging using magnetofluorescent polymeric nanoparticles functionalized with bombesin
Chang-Moon Lee1, Hwan-Jeong Jeong, Su-Jin Cheong
1Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital, 634-18, Geumam-2 dong, Dukjin-gu, Jeonju, Jeonbuk, 561-712, Republic of Korea.
Pharmaceutical Research
|February 26, 2010
Summary
Novel magnetofluorescent nanoparticles targeting prostate cancer were developed. Bombesin conjugation enhanced tumor accumulation, showing promise for in vivo cancer imaging and potential MRI applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Medical Imaging
Background:
- Prostate cancer imaging requires targeted, sensitive probes.
- Polymeric nanoparticles offer versatile platforms for drug delivery and imaging.
- Targeting specific receptors overexpressed on cancer cells enhances imaging specificity.
Purpose of the Study:
- To prepare and characterize magnetofluorescent polymeric nanoparticles for in vivo prostate cancer imaging.
- To evaluate the targeting efficiency of bombesin-conjugated nanoparticles.
- To explore the potential of these nanoparticles for magnetic resonance imaging (MRI).
Main Methods:
- Glycol chitosan was modified with N-acetyl histidine and conjugated with bombesin (BBN).
- Nanoparticles were labeled with a near-infrared (NIR) fluorophore (Cy5.5).
- Iron oxide nanoparticles (IO) were incorporated for MRI capabilities.
Main Results:
- BBN-conjugated nanoparticles demonstrated significantly higher binding to PC3 cancer cells compared to non-conjugated ones.
- In vivo studies showed improved tumor accumulation and tumor-to-muscle ratios with BBN-conjugated nanoparticles.
- Iron oxide-loaded nanoparticles were effectively visualized in PC3 cells, indicating MRI potential.
Conclusions:
- Bombesin conjugation enhances the tumor-targeting ability of NAHis-GC nanoparticles.
- These magnetofluorescent nanoparticles show significant potential for prostate cancer imaging.
- The developed nanoparticles could serve as theranostic agents for combined imaging and therapy.
